These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

55 related articles for article (PubMed ID: 1285033)

  • 1. Thyroid stimulating immunoglobulins are not influenced by smoking in healthy subjects.
    Hegedüs L; Bliddal H; Karstrup S; Bech K
    Thyroidology; 1992 Aug; 4(2):91-2. PubMed ID: 1285033
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Thyroid adenylate cyclase stimulating immunoglobulins in thyroid diseases.
    Bech K; Nistrup Madsen S
    Clin Endocrinol (Oxf); 1979 Jul; 11(1):47-58. PubMed ID: 583261
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunoglobulins of patients recovering from Yersinia enterocolitica infections exhibit Graves' disease-like activity in human thyroid membranes.
    Wolf MW; Misaki T; Bech K; Tvede M; Silva JE; Ingbar SH
    Thyroid; 1991; 1(4):315-20. PubMed ID: 1688156
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Thyroid hormones in generalized scleroderma. A controlled study.
    Serup J; Hangdrup H
    Acta Derm Venereol; 1986; 66(1):35-8. PubMed ID: 2424212
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Low response of the thyroid gland to endogenous thyrotropin increased by thyrotropin-releasing hormone in patients with euthyroid Graves' disease.
    Kashiwai T; Tada H; Watanabe Y; Shimaoka Y; Yagoro A; Hidaka Y; Fujikado T; Amino N
    Thyroid; 1998 Oct; 8(10):881-5. PubMed ID: 9827654
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of thyrotropin-releasing hormone on serum thyroid hormones: a study in the patients with untreated and treated Graves' disease and subacute thyroiditis.
    Sato A; Yamada T; Aizawa T; Ichikawa K; Komiya I; Takasu N; Takemura Y
    J Clin Endocrinol Metab; 1995 Jul; 80(7):2173-7. PubMed ID: 7608274
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Smoking-related Alterations in Serum Levels of Thyroid Hormones and Insulin in Female and Male Students.
    Meral I; Arslan A; Him A; Arslan H
    Altern Ther Health Med; 2015; 21(5):24-9. PubMed ID: 26393988
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Thyroid-stimulating antibody is related to Graves' ophthalmopathy, but thyrotropin-binding inhibitor immunoglobulin is related to hyperthyroidism in patients with Graves' disease.
    Noh JY; Hamada N; Inoue Y; Abe Y; Ito K; Ito K
    Thyroid; 2000 Sep; 10(9):809-13. PubMed ID: 11041459
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The influence of smoking habits on thyroid gland volume: an ultrasonic approach.
    Georgiadis E; Papapostolou C; Korakis T; Evagelopoulou K; Mantzoros C; Batrinos M
    J R Soc Health; 1997 Dec; 117(6):355-8. PubMed ID: 9519672
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [The relationship between serum thyroid autoantibodies, iodine intake, development and prognosis of Graves' disease].
    Chen W; Man N; Li YS; Shan ZY; Teng WP
    Zhonghua Nei Ke Za Zhi; 2006 Feb; 45(2):95-9. PubMed ID: 16624113
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Use of FRTL-5 for the study of thyroid antibodies involved in goitrogenesis.
    Vitti P; Chiovato L; Tonacchera M; Bendinelli G; Mammoli C; Capaccioli A; Giachetti M; Pinchera A
    Thyroidology; 1992 Apr; 4(1):49-51. PubMed ID: 1284334
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antithyroid drugs inhibit radioiodine-induced increases in thyroid autoantibodies in hyperthyroid Graves' disease.
    Nakazato N; Yoshida K; Mori K; Kiso Y; Sayama N; Tani JI; Nakagawa Y; Ito S
    Thyroid; 1999 Aug; 9(8):775-9. PubMed ID: 10482369
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of effects of high and low dosage regimens of antithyroid drugs in the management of Graves' hyperthyroidism.
    Romaldini JH; Bromberg N; Werner RS; Tanaka LM; Rodrigues HF; Werner MC; Farah CS; Reis LC
    J Clin Endocrinol Metab; 1983 Sep; 57(3):563-70. PubMed ID: 6192139
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Postpartum recurrence of hyperthyroidism and changes of thyroid-stimulating immunoglobulins in Graves' disease.
    Yabu Y; Amino N; Mori H; Miyai K; Tanizawa O; Takai SI; Kumahara Y; Matsuzuka F; Kuma K
    J Clin Endocrinol Metab; 1980 Dec; 51(6):1454-8. PubMed ID: 6108332
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Continued suppression of serum TSH level may be attributed to TSH receptor antibody activity as well as the severity of thyrotoxicosis and the time to recovery of thyroid hormone in treated euthyroid Graves' patients.
    Chung YJ; Lee BW; Kim JY; Jung JH; Min YK; Lee MS; Lee MK; Kim KW; Chung JH
    Thyroid; 2006 Dec; 16(12):1251-7. PubMed ID: 17199435
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Thyroid response, especially to thyrotropin-binding inhibitory immunoglobulins, in euthyroid relatives of patients with Graves' disease: a clinical follow-up.
    Tamai H; Kasagi K; Morita T; Hidaka A; Kuma K; Konishi J; Kumagai LF; Nagataki S
    J Clin Endocrinol Metab; 1990 Jul; 71(1):210-5. PubMed ID: 1973421
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effects of plasma from patients with Graves' disease on foetal mouse hearts in organ culture.
    Nathan AW; Longmore DB; Havard CW; Dandona P
    Br J Exp Pathol; 1983 Oct; 64(5):474-8. PubMed ID: 6139124
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [A study using FRTL-5 cell for detecting thyroid stimulating antibody activity in serum in patients with Graves disease].
    Li J; Gao H; Jin SX
    Zhonghua Nei Ke Za Zhi; 1991 Jul; 30(7):392-4, 454. PubMed ID: 1684315
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serum thyroid-stimulating antibody, thyroglobulin levels, and thyroid suppressibility measurement as predictors of the outcome of combined methimazole and triiodothyronine therapy in Graves' disease.
    Werner RS; Romaldini JH; Farah CS; Werner MC; Bromberg N
    Thyroid; 1991; 1(4):293-9. PubMed ID: 1688155
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Graves' ophthalmopathy in the absence of elevated free thyroxine and triiodothyronine levels: prevalence, natural history, and thyrotropin receptor antibody levels.
    Khoo DH; Eng PH; Ho SC; Tai ES; Morgenthaler NG; Seah LL; Fong KS; Chee SP; Choo CT; Aw SE
    Thyroid; 2000 Dec; 10(12):1093-100. PubMed ID: 11201855
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.